Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism (2010)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.thromres.2010.02.015
- Subjects: EMBOLIA PULMONAR; FIBRINÓLISE
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2010
- Source:
- Título do periódico: Thrombosis Research
- ISSN: 0049-3848
- Volume/Número/Paginação/Ano: v. 125, n. 6, p. 549-553, 2010
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MÜHL, Diána et al. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thrombosis Research, v. 125, n. 6, p. 549-553, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2010.02.015. Acesso em: 13 jun. 2024. -
APA
Mühl, D., Ghosh, S., Uzuelli, J. A., Lantos, J., & Tanus-Santos, J. E. (2010). Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thrombosis Research, 125( 6), 549-553. doi:10.1016/j.thromres.2010.02.015 -
NLM
Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism [Internet]. Thrombosis Research. 2010 ; 125( 6): 549-553.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.thromres.2010.02.015 -
Vancouver
Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism [Internet]. Thrombosis Research. 2010 ; 125( 6): 549-553.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.thromres.2010.02.015 - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1016/j.thromres.2010.02.015 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
